Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 18Active not recruiting 4Unknown 3Withdrawn 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 10Pancreatic Neoplasms 8Colorectal Neoplasms 8Rectal Neoplasms 7Neoplasm Metastasis 4Colorectal Cancer Metastatic 4Stomach Neoplasms 3Ovarian Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Gallbladder Neoplasms 2Carcinoma, Merkel Cell 2Biliary Tract Neoplasms 2Zollinger-Ellison Syndrome 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Somatostatinoma 1Sarcoma 1Prostatic Neoplasms 1Pheochromocytoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Multiple Endocrine Neoplasia Type 2b 1Multiple Endocrine Neoplasia Type 2a 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Gemcitabine 2Capecitabine 2galactomannan 1Sevoflurane 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1Oxaliplatin 1MK 2206 1Laser Therapy 1Irinotecan 1IMC-001 1Fluorouracil 1Dihematoporphyrin Ether 1Desflurane 1Cisplatin 1Chemotherapy, Adjuvant 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gallbladder Neoplasms × Capecitabine × Clear all
NCT03579758 2020-06-05

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Emory University

Phase 3 Withdrawn
Gastrointestinal

Gallbladder Neoplasms

NCT02720601 2018-01-25

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

New Mexico Cancer Research Alliance

Phase 2 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡